ALGBE 📈 Glob Bioenergi - Overview
Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0011052257
ALGBE: Isobutene, Biofuels, Cosmetic Ingredients, Chemical Compounds, Aviation Fuel
Global Bioenergies SA engages in the development of a process for converting plant-based feedstocks into isobutene used in the cosmetic and aviation fuel industry. The company also offers engineering services in gas fermentation process. In addition, it develops a process to convert gaseous carbon sources, such as CO2, CO, and industrial emissions comprising syngas into various chemical compounds. The company was incorporated in 2008 and is headquartered in Evry, France. Web URL: https://www.global-bioenergies.com
Additional Sources for ALGBE Stock
ALGBE Stock Overview
| Market Cap in USD | 15m |
| Sector | Utilities |
| Industry | Utilities - Diversified |
| GiC Sub-Industry | Commodity Chemicals |
| IPO / Inception |
ALGBE Stock Ratings
| Growth 5y | -83.3% |
| Fundamental | 28.5% |
| Dividend | - |
| Rel. Strength Industry | -5775 |
| Analysts | - |
| Fair Price Momentum | 0.61 EUR |
| Fair Price DCF | - |
ALGBE Dividends
No Dividends PaidALGBE Growth Ratios
| Growth Correlation 3m | -66% |
| Growth Correlation 12m | -87.8% |
| Growth Correlation 5y | -66.4% |
| CAGR 5y | -21.83% |
| CAGR/Mean DD 5y | -0.40 |
| Sharpe Ratio 12m | -0.35 |
| Alpha | -88.42 |
| Beta | 1.13 |
| Volatility | 45.95% |
| Current Volume | 8.7k |
| Average Volume 20d | 20.2k |
What is the price of ALGBE stocks?
As of December 27, 2024, the stock is trading at EUR 0.85 with a total of 8,654 shares traded.
Over the past week, the price has changed by +1.44%, over one month by +2.18%, over three months by -41.64% and over the past year by -57.54%.
As of December 27, 2024, the stock is trading at EUR 0.85 with a total of 8,654 shares traded.
Over the past week, the price has changed by +1.44%, over one month by +2.18%, over three months by -41.64% and over the past year by -57.54%.
Is Glob Bioenergi a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Glob Bioenergi is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.50 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALGBE as of December 2024 is 0.61. This means that ALGBE is currently overvalued and has a potential downside of -28.24%.
Neither. Based on ValueRay Fundamental Analyses, Glob Bioenergi is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 28.50 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ALGBE as of December 2024 is 0.61. This means that ALGBE is currently overvalued and has a potential downside of -28.24%.
Is ALGBE a buy, sell or hold?
Glob Bioenergi has no consensus analysts rating.
Glob Bioenergi has no consensus analysts rating.
What are the forecast for ALGBE stock price target?
According to ValueRays Forecast Model, ALGBE Glob Bioenergi will be worth about 0.7 in December 2025. The stock is currently trading at 0.85. This means that the stock has a potential downside of -22.35%.
According to ValueRays Forecast Model, ALGBE Glob Bioenergi will be worth about 0.7 in December 2025. The stock is currently trading at 0.85. This means that the stock has a potential downside of -22.35%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 2.4 | 182.4% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 0.7 | -22.4% |